Professor Obinna Onwujekwe is one of the leading health economists in Africa. He is medically qualified (MD) but also has a MSc (Health Economics); Certificate in Health Management; Post-graduate Diploma (PGD) in Public Health and Policy; and a PhD (Health Economics & Policy). He is currently a Professor of Health Economics & Policy and Pharmacoeconomics & Pharmacoepidemiology at the University of Nigeria. He is the coordinator of the Health Policy Research Group, the Director of Research at the University of Nigeria the current President of the Nigerian Health Economics Association and former Chairman of the Scientific Committee of the African Health Economics and Policy Association (AfHEA). He is a member of the Resilient and Responsive Health Systems (RESYST) international consortium. He has directly mentored more than 50 students who have gone on to successful obtain academic positions in various Nigerian universities, win research grants and continues to conduct research. He has extensively collaborated with international agencies, including serving as Principal Investigator or co-Investigator on more than a dozen grants funded by the UK Department for International Development, the World Health Organization, the World Bank, the Gates Foundation, the National Institutes of Health and the United Nations Population Fund, among others. He has consulted widely for many national and international organizations and has working experiences in several countries. He has published more than 300 academic and policy papers. His detailed profile at: https://www.researchgate.net/profile/Obinna_Onwujekwe; http://scholar.google.com/citations?user=lVcCp5gAAAAJ&hl=en
Area of research interest: Implementation Research; Health Technology Assessment; Universal Health Coverage; Financial Risk Protection, especially different health insurance mechanisms; Equity in health and healthcare; Health Sector Reform; Health Policy and Systems Research; Economic analysis/evaluation; Economic burden of communicable and non-communicable diseases; Reliability and validity of contingent valuation method; Getting research into strategy, policy and practise (GRIPP and GRISPP).